Meta-Iodobenzylguanidine (I-123) imaging agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Meta-Iodobenzylguanidine (I-123) imaging agent, covering 2017-05-05 to 2017-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease [Phase 3]